Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
Zeba Ahmad, Ph.D. · with American Cancer Society, Inc. · NCT07139769
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 48
- US sites recruiting
- 1
- Study start
- September 2026
- Record last updated
- August 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP (E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYAs with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
Being studied: Psychosocial Intervention for Parental Caregivers of AYA with Cancer
Conditions: Caregiving for Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Self-identifying parent/guardian who provides a primary informal caregiving role in their child's cancer
- Recipient of caregiving is aged between 15 and 39 years and is receiving treatment for cancer at the Mass General Brigham Cancer
- Participant must score equal to or greater than 2 (out of a possible 10) on the National Comprehensive Cancer Network Distress Thermometer
- English-speaking
- Aged over 18 years
Exclusion Criteria
-Active symptoms of psychosis or suicidal ideation that would preclude safe participation
Recruiting US locations
Mass General Brigham Cancer Institute at Massachusetts General Hospital
Boston, MA 02114
Site contact: Zeba Ahmad, Ph.D. · 631-786-0403 · zahmad7@gmail.com
Study contacts (from the official record)
- Zeba N Ahmad, Ph.D. · 16177241586 · zahmad2@mgh.harvard.edu
- Katana Corning, B.A. · 6177247593 · kcorning@mgh.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+